Trial intelligence / Profile preview

PA101B in Uremic Pruritus

NCT02696499Phase 2Completed

Sponsor
Patara Pharma
Start
Feb 2016
Primary completion
Aug 2016
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of sodium cromoglycate in uremic pruritus, sponsored by Patara Pharma. Started Feb 2016; status: completed.

02

Drugs

sodium cromoglycate
03

Conditions

uremic pruritus

Beyond the preview

Go deeper on NCT02696499.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02696499.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call